Development of a physiology-directed population pharmacokinetic and pharmacodynamic model for characterizing the impact of genetic and demographic factors on clopidogrel response in healthy adults.
about
Influence of genetic co-factors on the population pharmacokinetic model for clopidogrel and its active thiol metabolite.Identifying clinically relevant sources of variability: The clopidogrel challenge.Modelling the delay between pharmacokinetics and EEG effects of morphine in rats: binding kinetic versus effect compartment models
P2860
Development of a physiology-directed population pharmacokinetic and pharmacodynamic model for characterizing the impact of genetic and demographic factors on clopidogrel response in healthy adults.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Development of a physiology-di ...... el response in healthy adults.
@en
type
label
Development of a physiology-di ...... el response in healthy adults.
@en
prefLabel
Development of a physiology-di ...... el response in healthy adults.
@en
P2093
P2860
P1476
Development of a physiology-di ...... el response in healthy adults.
@en
P2093
Joshua P Lewis
Lambertus A Peletier
Laura M Yerges-Armstrong
Lawrence J Lesko
Richard B Horenstein
Snehal Samant
Stephan Schmidt
Xi-Ling Jiang
P2860
P356
10.1016/J.EJPS.2015.10.024
P407
P577
2015-10-30T00:00:00Z